Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
W Zhang, WM van Weerden, CMA de Ridder… - The …, 2019 - Wiley Online Library
Background In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
[PDF][PDF] Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
W Zhang, WM van Weerden, CMA de Ridder… - Prostate Cancer and …, 2019 - core.ac.uk
Background In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable organotypic …
anticancer treatment efficacy. This limitation may be overcome by using viable organotypic …
[HTML][HTML] Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
W Zhang, WM van Weerden, CMA de Ridder… - The Prostate, 2019 - ncbi.nlm.nih.gov
Background In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
W Zhang, W van Weerden, C de Ridder… - The Prostate, 2018 - repub.eur.nl
Background: In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response.
W Zhang, WM van Weerden, CMA de Ridder… - The Prostate, 2018 - europepmc.org
Background In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
W Zhang, WM van Weerden, CMA de Ridder… - The …, 2019 - pubmed.ncbi.nlm.nih.gov
Background In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
[PDF][PDF] Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
W Zhang, WM van Weerden, CMA de Ridder… - 2018 - core.ac.uk
Background: In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
anticancer treatment efficacy. This limitation may be overcome by using viable tumor slice …
[PDF][PDF] Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
W Zhang, WM van Weerden, CMA de Ridder… - Prostate Cancer and …, 2019 - repub.eur.nl
Background In vitro models of prostate cancer (PCa) are not always reliable to evaluate
anticancer treatment efficacy. This limitation may be overcome by using viable organotypic …
anticancer treatment efficacy. This limitation may be overcome by using viable organotypic …